Bifren Phenibut 250mg 20 caps
asthenic and anxious-neurotic states (emotional lability, memory impairment, decreased concentration of attention), anxiety, fear, anxiety, obsessive-compulsive disorder; in children – stuttering, enuresis, tics; in the elderly – insomnia, night anxiety; prevention of stressful conditions, before surgery or painful diagnostic tests; as an adjunct in the treatment of withdrawal symptoms in alcoholism; also prescribe for Meniere’s disease, dizziness associated with dysfunction of the vestibular apparatus, for the prevention of motion sickness.
Free International Shipping
Bifren Phenibut Indications
Decrease in intellectual and emotional activity, memory impairment, poor concentration.
Asthenic and anxious-neurotic states, anxiety, fear, anxiety, obsessive-compulsive disorder, personality disorder; children – stuttering, enuresis, tics; in the elderly – insomnia, night restlessness.
Preventing stress, before surgery or painful diagnostic studies.
BIGF used as an adjunct in the treatment of alcoholism and to stop somatovegetativnyh psychopathological disorders at a syndrome of abstinence.
The drug can be used in conjunction with conventional detoxication agents for the treatment of alcoholic predelirioznyh and delirious states.
Meniere’s disease, vertigo associated with dysfunction of the vestibular system, for prevention of motion sickness. It is used in treatment of women with osteochondrosis of the cervical-thoracic spine and climacteric disorders.
Dosage & Administration
Before a meal, with water.
Adults appoint 250-500 mg 3 times a day. The highest single dose: adults – 750 mg for patients older than 60 years – 500 mg. The course of treatment is 4-6 weeks.
Children under the age of 11 years – 250 mg 2-3 times a day.
BIGF be combined with other psychotropic agents, it increases its efficiency. Thus it is possible to reduce the dose of bIGF other simultaneously used drugs.
For treatment of alcohol withdrawal syndrome bIGF in the first days of treatment appoint 250-500 mg 3 times daily and 750 mg at bedtime, with a gradual decrease in the daily dose to normal adult.
To eliminate vertigo vestibular dysfunction of infectious origin (otogenny labyrinthitis) and Meniere’s disease in acute bIGF appoint 750 mg 3 times a day for 5-7 days, with a decrease in the severity of vestibular disorders – 250-500 mg 3 times a day for 5-7 days, and then – 250 mg 1 time per day for 5 days. At relatively mild disease bIGF taking 250 mg 2 times a day for 5-7 days, and then – 250 mg 1 time per day for 7-10 days.
To eliminate vertigo vestibular dysfunction of vascular and traumatic genesis bIGF appoint 250 mg 3 times daily for 12 days.
Hypersensitivity to the drug.
Acute renal failure.
Children under 11 years old.